Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment &lt;sup&gt;18&lt;/sup&gt;F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Feng-Ming Spring Kong; Chen Hu; Daniel A Pryma; Fenghai Duan; Martha Matuszak; Ying Xiao; Randall Ten Haken; Marilyn J Siegel; Lucy Hanna; Walter J Curran; Mark Dunphy; Daphna Gelblum; Morand Piert; Shruti Jolly; Clifford G Robinson; Andrew Quon; Billy W Loo; Shyam Srinivas; Gregory M Videtic; Sergio L Faria; Catherine Ferguson; Neal E Dunlap; Vijayananda Kundapur; Rebecca Paulus; Barry A Siegel; Jeffrey D Bradley; Mitchell Machtay
NRG Oncology Statistics and Data Management Center, Philadelphia, PA. ; US and ECOG-ACRIN Biostatistics Center, Brown University, Providence, RI.